Navigation Links
Erection Drugs Don't Boost Men's Self-esteem

Erection drugs may give a man's performance in bed a boost, but they don't have the same effect on their self-esteem or their relationships .

A survey of 650 Aussie men found that while those with erectile problems have poorer esteem, a weaker sense of masculinity and lower personal satisfaction.

Of these 400 men had erectile dysfunction (ED), including half who had tried drug treatment, and another 250 men with normal sexual function.

However, there was no difference in the levels of the above for men who were taking erection drugs like Viagra.

Lead researcher and psychologist Hayley Matic said that the survey showed that pills like these are not enough to give self-esteem a boost.

The findings contradict earlier surveys that show that Viagra and other drugs give men's esteem a boost.

"This just goes to show that medications are not a magic pill to improve the sex lives of men," News.com.au quoted Dr Matic, as saying.

"Overall, wellbeing was not improved in the men who had used medical interventions for their ED."

"In fact there was no difference in the reports, regardless of whether they were on drugs," Dr Matic added.

A spokesman for Viagra manufacturer Pfizer, maintained that the drug "improved the sex lives of more than 30 million men worldwide".

The findings will be published in the International Journal of Impotence Research.


'"/>




Page: 1

Related medicine news :

1. Young Men Treating Erection Problems without Doctors Prescription
2. Erection Drug Was Not Useful to Two-Thirds of Its Users
3. Health Drink Blamed for Persistent Penile Erection
4. Lean Protein Could Be Key to Obesity Drugs
5. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
6. Nasal Spray Could Take Drugs Direct to Brain.
7. Emphasis to ban Drugs ads by Doctors
8. Osteoporosis Drugs: right time to take-off
9. Drugs disrupt formation of blood vessels
10. Drugs to stop burgeon of HIV
11. Misleading Advertisements for Prescription Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Erection Drugs Don Boost Men Self esteem

(Date:12/7/2009)... selected a Texas Wind Integration project team including Drummond Group ... smart grid demonstration project. Drummond Group,s role is overseeing the ... with strong support from the project stakeholders. , ... ... -- The Department of Energy has selected a ...
(Date:12/7/2009)... Content throughout the Clinical Workflow , ... ... Institutions currently using point-of-care resources from EBSCO Publishing ... benefit from a new agreement which gives healthcare providers ... retrieval of relevant and current information and improved quality ...
(Date:12/7/2009)... , ... Phoenix, AZ (PRWEB) December 7, 2009 -- ... spinal cord injury: The online retailer of medical supplies ... , ,Cure Medical is a forward-thinking manufacturer of catheters. In ... the company donates 10 percent of all of their pre-tax profits ...
(Date:12/7/2009)... agency A.R.M. Solutions was recognized as a leader in the ... award-winning recovery service outperforms traditional collection agencies in speed, cost, ... ... December 7, 2009 -- A.R.M. Solutions, a leading provider of ... Places to Work in Collections by insideARM.com. This is the ...
(Date:12/7/2009)... Cell Therapeutics, Inc. ("CTI") (Nasdaq and ... of St. George,s Hospital, University of London during ... Hematology ("ASH") Annual Meeting updated results from the ... of pixantrone (the "PIX 301 EXTEND trial") in ... patients who have failed 2 or more prior ...
Breaking Medicine News(10 mins):Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 2Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 3Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 4Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:Online Medical Supply Superstore Adds Cure Catheters to Product Mix 2Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5
... N.J., March 23 Siemens Financial Services, Inc. ... in tax-exempt financing to El Camino Hospital in ... used to acquire a variety of Siemens Medical ... new El Camino hospital under construction.(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
... Krapf of Bear, DE, will travel to Washington, ... to meet with congressional leaders and gain their support ... a cure for epilepsy.Krapf, 13, is one of 37 ... Kids Speak Up! , a national program coordinated by ...
... COLUMBIA, S.C., March 23 /PRNewswire-USNewswire/ -- BlueCross ... state to participate in the third annual National Walk ... nationwide will encourage their employees to take part in ... workers to take time regularly during their lunch breaks ...
... Money and Improves Health With Advanced but Affordable ... money and save your health in these tough ... part medical detective as well as a skilled ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-b ) , (Photo: ...
... that a disturbing number of children ,wag, breakfast claiming there ... ,can,t be bothered, having a meal before going to school. ... their children skip breakfast on three to five school days ... one or two school days. , The remaining 58% of ...
... of Liverpool have demonstrated how a single-celled organism, living ... Salmonella transmission to animals and humans. , ... contaminate almost any food type, causing diarrhoea, abdominal pain ... which can also cause typhoid fever has ...
Other Medicine News:Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 3Health News:Delaware Youth Shares Epilepsy Message on Capitol Hill 2Health News:S.C. BlueCross Issues National Walk at Lunch Day Challenge to Employers 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 3Health News:School kids 'wagging' breakfast are missing healthy brain fuel 2Health News:Study shows how Salmonella survives in environment 2
(Date:12/4/2009)... BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a ... today announced the initial development and successful testing of ... Axsun believes this proprietary optical engine design raises ... of laser-based designs for swept source OCT light sources. ...
(Date:12/4/2009)... Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an ... and Drug Administration seeking approval to market its 8mg ... owned by Takeda Pharmaceutical Company Limited. Watson,s 8mg ...
(Date:12/4/2009)... Neal Shore and E. David Crawford presented results for ... secondary end points of biochemical recurrence rate in a ... injection) or monthly leuprolide in prostate cancer patients during ... who received FIRMAGON 240/80 mg/month had a recurrence rate ...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Milestone Scientific Announces Notice of Allowance From US Patent and Trademark Office 55116 1Milestone Scientific Announces Notice of Allowance From US Patent and Trademark Office 55116 2Milestone Scientific Announces Notice of Allowance From US Patent and Trademark Office 55116 3School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign 55114 1School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign 55114 2School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign 55114 3School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign 55114 4Portola Pharmaceuticals Announces Two Oral Presentations on Elinogrel at European Society of Cardiology Congress 2009 13658 1Portola Pharmaceuticals Announces Two Oral Presentations on Elinogrel at European Society of Cardiology Congress 2009 13658 2
... CR011-vcMMAE for ... melanoma -, - Preliminary Phase I/II results to be presented in June ... ... CRGN ), a clinical-stage biopharmaceutical company,focused on oncology, announced today that it has ...
... ORENCIA is a First-in-Class Biologic Treatment Option Now Available for ... Use in Pediatric Patients with JIA(1,2) ... (NYSE: BMY ) today announced that the U.S. Food ... symptoms in pediatric patients six years and older with moderately ...
Other Medicine Technology:CuraGen Advances CR011-vcMMAE into Phase II 2CuraGen Advances CR011-vcMMAE into Phase II 3CuraGen Advances CR011-vcMMAE into Phase II 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10
... The Acuity LT Central Monitoring Station provides ... and ready to go right out of ... surveillance in specific care areas rather than ... ICU. As patient-to-caregiver ratios continue to climb ...
... oximetry without the weight or ... to full-featured capability, the 3775 ... that clinicians need, when they ... full-featured handheld oximeter is designed ...
... One of the smallest handheld oximeters available, ... solution for hospital, home care, transport, and ... features., ,PIr (relative perfusion index measurement) ... a dynamic numeric reflection of perfusion at ...
... and Researchers., ,S/5 Collect and S/5 Collect4 ... to collect data from Datex-Ohmeda monitors. Data can ... time intervals. With S/5 Collect you have ability ... an interface cable or connect directly from S/5 ...
Medicine Products: